Your browser doesn't support javascript.
loading
The Association between Single Nucleotide Polymorphisms, including miR-499a Genetic Variants, and Dyslipidemia in Subjects Treated with Pharmacological or Phytochemical Lipid-Lowering Agents.
Giuliani, Angelica; Montesanto, Alberto; Matacchione, Giulia; Graciotti, Laura; Ramini, Deborah; Protic, Olga; Galeazzi, Roberta; Antonicelli, Roberto; Tortato, Elena; Bonfigli, Anna Rita; Sabbatinelli, Jacopo; Olivieri, Fabiola.
Affiliation
  • Giuliani A; Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, 60126 Ancona, Italy.
  • Montesanto A; Department of Biology, Ecology and Earth Sciences, University of Calabria, 87036 Rende, Italy.
  • Matacchione G; Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, 60126 Ancona, Italy.
  • Graciotti L; Department of Excellence SBSP-Biomedical Sciences and Public Health, Università Politecnica delle Marche, 60126 Ancona, Italy.
  • Ramini D; Center of Clinical Pathology and Innovative Therapy, IRCCS INRCA, 60121 Ancona, Italy.
  • Protic O; Cardiology Unit, IRCCS INRCA, 60127 Ancona, Italy.
  • Galeazzi R; Clinical Laboratory and Molecular Diagnostic, IRCCS INRCA, 60127 Ancona, Italy.
  • Antonicelli R; Cardiology Unit, IRCCS INRCA, 60127 Ancona, Italy.
  • Tortato E; Metabolic Diseases and Diabetology Department, IRCCS INRCA, 60127 Ancona, Italy.
  • Bonfigli AR; Scientific Direction, IRCCS INRCA, 60124 Ancona, Italy.
  • Sabbatinelli J; Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, 60126 Ancona, Italy.
  • Olivieri F; Laboratory Medicine Unit, Azienda Ospedaliero Universitaria Ospedali Riuniti, 60126 Ancona, Italy.
Int J Mol Sci ; 23(10)2022 May 17.
Article in En | MEDLINE | ID: mdl-35628426
Disorders of lipoprotein metabolism are among the major risk factors for cardiovascular disease (CVD) development. Single nucleotide polymorphisms (SNPs) have been associated with the individual variability in blood lipid profile and response to lipid-lowering treatments. Here, we genotyped 34 selected SNPs located in coding genes related to lipid metabolism, inflammation, coagulation, and a polymorphism in the MIR499 gene-a microRNA previously linked to CVD-to evaluate the association with lipid trait in subjects with moderate dyslipidemia not on lipid-lowering treatment (Treatment-naïve (TN) cohort, n = 125) and in patients treated with statins (STAT cohort, n = 302). We also explored the association between SNPs and the effect of a novel phytochemical lipid-lowering treatment in the TN cohort. We found that 6 SNPs (in the MIR499, TNFA, CETP, SOD2, and VEGFA genes) were associated with lipid traits in the TN cohort, while no association was found with the response to twelve-week phytochemical treatment. In the STAT cohort, nine SNPs (in the MIR499, CETP, CYP2C9, IL6, ABCC2, PON1, IL10, and VEGFA genes) were associated with lipid traits, three of which were in common with the TN cohort. Interestingly, in both cohorts, the presence of the rs3746444 MIR499 SNP was associated with a more favorable blood lipid profile. Our findings could add information to better understand the individual genetic variability in maintaining a low atherogenic lipid profile and the response to different lipid-lowering therapies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / MicroRNAs / Dyslipidemias / Hypolipidemic Agents Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Int J Mol Sci Year: 2022 Type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / MicroRNAs / Dyslipidemias / Hypolipidemic Agents Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Int J Mol Sci Year: 2022 Type: Article Affiliation country: Italy